Open Access iconOpen Access

ARTICLE

Ampelopsin Inhibits Breast Cancer Glucose Metabolism Reprogramming Based on Network Pharmacology and Molecular Docking

Rong Zeng1,#, Lin Liu1,2,#, Jingshan Zhao1,2,3,#, Wenmei Zhang3, Guohong Zhang1, Yunfeng Li1,2,*

1 Hebei Key Laboratory of Chinese Medicine Research on Cardiocerebrovascular Disease, Hebei University of Chinese Medicine, Shijiazhuang, 050200, China
2 Department of Biochemistry and Molecular Biology, College of Basic Medicine, Hebei University of Chinese Medicine, Shijiazhuang, 050200, China
3 College of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, 050200, China

* Corresponding Author: Yunfeng Li. Email: email
# These authors contributed equally to this work

TSP_ONCOLOGIE_25148.pdf

  • 1027

    View

  • 628

    Download

  • 0

    Like

Share Link